Search results
Annexon, Inc. (NASDAQ:ANNX) Receives $14.14 Average Price Target from Analysts
ETF DAILY NEWS· 4 days agoShares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have earned an average recommendation of “Buy” from the six research firms that are presently covering the stock, MarketBeat reports.
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent...
CBS 47 Fresno· 7 days agoSeelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders ...
Cantor Fitzgerald Comments on Annexon, Inc.’s FY2024 Earnings (NASDAQ:ANNX)
ETF DAILY NEWS· 6 days agoAnnexon, Inc. (NASDAQ:ANNX – Free Report) – Stock analysts at Cantor Fitzgerald boosted their FY2024 earnings estimates for shares of Annexon in a research note issued on Tuesday, May 14th.
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent...
Benzinga· 7 days agoSeelos Therapeutics, Inc. SEEL ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and ...
Dying ex-doctor serving life for murder may soon be free after a conditional pardon and 2-year wait...
ABC 7 El Paso· 2 days agoVince Gilmer, the former North Carolina doctor whose murder conviction and medical mystery captured widespread attention after being documented in a popular radio show and a book, is set to ...